The protective effect of estradiol-17 beta against polycyclic hydrocarbon cytotoxicity.
D000818:Animals; D001391:Azo Compounds / Q000494:pharmacology; D001551:Benz(a)Anthracenes / Q000494:pharmacology*; D001940:Breast / Q000378:metabolism; D006528:Carcinoma, Hepatocellular / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects*; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D002478:Cells, Cultured; D003900:Desoxycorticosterone / Q000494:pharmacology; D004847:Epithelial Cells; D004848:Epithelium / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology*; D006367:HeLa Cells / Q000187:drug effects; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008113:Liver Neoplasms / Q000378:metabolism; D008168:Lung / Q000187:drug effects; D009369:Neoplasms / Q000139:chemically induced; D009374:Neoplasms, Experimental / Q000378:metabolism; D011374:Progesterone / Q000494:pharmacology; D051381:Rats; D013739:Testosterone / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D001391:Azo Compounds; D001551:Benz(a)Anthracenes; D014316:Tritium; D013739:Testosterone; D003900:Desoxycorticosterone; D011374:Progesterone; D004958:Estradiol; D013936:Thymidine; D006854:Hydrocortisone